2.1.2: Phosphodiesterase Type-3 inhibitors

Part of chapter 2 Cardiovascular System, section 2.1 Positive inotropic drugs


High-level prescribing trends for Phosphodiesterase Type-3 inhibitors (BNF section 2.1.2) across all GP practices in NHS England for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.

Chemicals

Enoximone (0201020G0)
Milrinone lactate (0201020M0)